EN PL

EMA: Concept paper on the need for a guideline on multiplicity issues in clinical trials

31.05.2012
The CHMP points to consider on multiplicity issues in clinical trials came into operation in 2002. Since then, it has been proven to be useful for both, industry and regulators when planning and assessing confirmatory clinical trials.